Multiple Myeloma
Featured Articles
(BMS) June 17, 2018 - Primary endpoint of progression-free survival met for the combination of Empliciti plus pomalidomide and low-dose dexamethasone; data will be presented for the first time in late-breaking oral session during the 23rd Congress of the European Hematology Association.
Read Article
(MedCity News) June 7, 2018 - Although bluebird bio’s CAR-T cell therapy for multiple myeloma is already in a registration-directed clinical trial, Janssen sees plenty of room to muscle in as well.
Read Article
Latest Articles
June 15, 2018
June 15, 2018
June 15, 2018
June 14, 2018
June 11, 2018
June 11, 2018
June 06, 2018
June 05, 2018
View More
News Commentary
Editor Image
02 Jan, 2018 | by Winston Wong, PharmD
These 7 Key Trends are definitely a continuation of what we have seen through...
View Comment
Editor Image
07 Mar, 2018 | by Dean Gesme, MD
I respect Dr Rajkumar's clinical expertise but here in MN we have a 2% state...
View Comment
View More
OBR Green
There are no Multiple Myeloma OBR Green articles.
OBR Blog
There are no Multiple Myeloma blog entries.